In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-16 of 16 for your search:
Drug:  mercaptopurine
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under at diagnosis
Sponsor: Other
Protocol IDs: 6-MP formulation, 2013-001236-21, NCT01906671

2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 30
Sponsor: Other
Protocol IDs: LAL-RI/2008, NCT02036489

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: Under 18
Sponsor: Other
Protocol IDs: POWH-CRE-2008.077-T, CDR0000595184, NCT00707083

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 35 to 70
Sponsor: NCI
Protocol IDs: NCI-2013-02229, ECOG-E1910, E1910, U10CA021115, U10CA180820, NCT02003222

5.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 1 to 30
Sponsor: NCI
Protocol IDs: NCI-2014-00631, COG-AALL1331, AALL1331, U10CA098543, U10CA180886, NCT02101853

6.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 2 to 30
Sponsor: NCI
Protocol IDs: NCI-2014-00712, AALL1231, U10CA180886, U10CA098543, NCT02112916

7.

Phase: Phase III
Type: Health services research, Treatment
Status: Active
Age: Under 16
Sponsor: Other
Protocol IDs: 2010001, NCT02200978

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 2 to 18
Sponsor: Other
Protocol IDs: JMC-2014-6TG/6MP, NCT02141100

9.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: PALG ALL6, NCT01665001

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: ALLR18, NCT01700946

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 55
Sponsor: Other
Protocol IDs: GMALL-PH-01, 2010-022854-18, NCT01724879

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: 12-266, NCT01920737

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 65 and over
Sponsor: NCI
Protocol IDs: NCI-2014-01047, SWOG-S1318, S1318, U10CA180888, NCT02143414

14.

Phase: Phase I
Type: Treatment
Status: Approved-not yet active
Age: 51 to 75
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: 14-200, NCT02228772

15.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 30 and under
Sponsor: Other
Protocol IDs: SIR-MO-1101, 2012-0361, NCT01658007

16.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 30 and under
Sponsor: Other
Protocol IDs: J1357, NA_00084984, NCT02046694
New Search